Ligand-targeted liposomal anticancer drugs

Progress in Lipid Research

Volumn 42, Issue 5, 2003, Pages 439-462

  Sapra, P ^a   Allen, T M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antibodies; Cancer; Doxorubicin; Drug targeting; Liposomes; Receptor ligands

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOHYDRATE; CD19 ANTIGEN; CISPLATIN; DOXORUBICIN; DRUG RECEPTOR; GANGLIOSIDE ANTIBODY; HYALURONIC ACID; IMMUNOGLOBULIN F(AB) FRAGMENT; LIGAND; LIGAND TARGETED LIPOSOME; LIPOSOME; NUCLEOSIDE DERIVATIVE; PROTEIN ANTIBODY; RECOMBINANT ANTIBODY; TRANSFERRIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE ANTIBODY; VINCRISTINE;

ANTIBODY ENGINEERING; ANTIGEN EXPRESSION; BINDING AFFINITY; BIOTECHNOLOGY; CANCER CELL CULTURE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; HUMAN; IMMUNOGENICITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0038797831     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7827(03)00032-8     Document Type: Review

References (146)

1. Northfelt D.W., Martin F.J., Working P., Volberding P.A., Russell J., Newman M.et al. J Clin Pharmacol. 36:1996;55-63.
2. Bangham A.D., Standish M.M., Watkins J.C. J Mol Biol. 13:1965;238-252.
3. Bolotin E.M., Cohen R., Bar L.K., Emanuel S.N., Lasic D.D., Barenholz Y. J Liposome Res. 4:1994;455-479.
4. Boman N.L., Masin D., Mayer L.D., Cullis P.R., Bally M.B. Cancer Res. 54:1994;2830-2833.
5. Allen T.M., Chonn A. FEBS Lett. 223:1987;42-46.
6. Gabizon A., Papahadjopoulos D. Proc Natl Acad Sci USA. 85:1988;6949.
7. Papahadjopoulos D., Gabizon A. Prog Clin Biol Res. 343:1990;85-93.
8. Allen T.M., Hansen C.B. Biochim Biophys Acta. 1068:1991;133-141.
9. Allen TM, Stuart D. In: Janoff AS, editor. Liposomes Rational Design. New York: Marcel Dekker, Inc., 1998:63-97.
10. Jan RK. Cancer Metastasis Rev 1987;559-93.
11. Yuan F., Leunig M., Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. Cancer Res. 54:1994;3352-3356.
12. Woodle MC, Storm G. Long-circulating liposomes: Old Drugs New Therapeutics. Landes Bioscience, Georgetown, TX 1998,1-206.
13. Allen T.M. Cooper E. PharmaTech. 2000;154-160 World Markets Research Centre, London.
14. Allen T.M., Hansen C.B., Lopes de Menezes D.E. Adv Drug Del Rev. 16:1995;267-284.
15. Ahmad I., Longenecker M., Samuel J., Allen T.M. Cancer Res. 53:1993;1484-1488.
16. Park J.W., Hong K., Kirpotin D.B., Meyer O., Papahadjopoulos D., Benz C.C. Cancer Lett. 118:1997;153-160.
17. Carter P. Nat Rev Cancer. 1:2001;118-129.
18. Baselga J., Norton L., Albanell J., Kim Y.M., Mendelsohn J. Cancer Res. 58:1998;2825-2831.
19. Demidem A., Lam T., Alas S., Hariharan K., Hanna N., Bonavida B. Cancer Biother Radiopharm. 12:1997;177-186.
20. Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V., Bajamonde Aet al. N Engl J Med. 344:2001;783-792.
21. Coiffier B., Lepage E., Briere J., Herbrecht R., Tilly H., Bouabdallah R.et al. N Eng J Med. 346:2002;235-242.
22. McLaughlin F., Grillo-Lopez A.J., Link B.K., Levy R., Czuczman M.S., Williams M.E.et al. J Clin Oncol. 16:1998;2825-2833.
23. Czuczman M.S., Grub-Lopez A.J., White C.A., Saleh M., Gordon L., LoBuglio A.F.et al. J Clin Oncol. 17:1999;268-276.
24. Safra T., Muggia F., Jeffers S., Tsao-Wei D.D., Groshen S., Lyass O.et al. Ann Oncol. 11:2000;1029-1033.
25. Pietras R.J., Fendly B.M., Chazin Y.R. Pergram MD. Oncogene. 9:1994;1829-1838.
26. Ghetie M.A., Picker L.J., Richardson J.A., Tucker K., Uhr J.W., Vitetta E.S. Blood. 83:1994;1329-1336.
27. Ghetie M.A., Ghetie V., Vitetta E.S. Clin Cancer Res. 5:1999;3920-3927.
28. Bradbury L.B. Kansas GS, Levy S, Evans RL, Tedder TF.J Immunol. 149:1992;2841-2850.
29. Allen T.M., Brandeis E., Hansen C.B., Kao G.Y., Zalipsky S. Biochim Biophys Acta. 1237:1995;99-108.
30. Allen T.M., Hansen C.B., Zalipsky S. Lasic D.D., Martin F. Stealth Liposomes. 1995;193-202 CRC Press, Inc, Boca Raton, FL.
31. Debs R.J., Heath T.D., Papahadjopoulos D. Biochim Biophys Acta. 901:1987;183-190.
32. Derksen J.T.P., Morselt H.W.M., Scherphof G.L. Biochim Biophys Acta. 917:1988;127-136.
33. Klibanov A.L., Maruyama K., Beckerleg A.M., Torchilin V.P., Huang L. Biochim Biophys Acta. 1062:1991;142-148.
34. Maruyama K., Takizawa T., Takahashi N., Tagawa T., Nagaike K., Iwatsuru M. Adv Drug Del Rev. 24:1997;235-242.
35. Blume G., Cevc G. Biochim Biophys Acta. 1146:1993;157-168.
36. Maruyama K., Takizawa T., Yuda T., Kennel S.J., Huang L., Iwatsuru M. Biochim Biophys Acta. 1234:1995;74-80.
37. Zalipsky S. Bioconjug Chem. 4:1993;296-299.
38. Kirpotin D., Park J.W., Hong K., Zalipsky S., Li W-L, Carter P., Benz C.C., Papahadjopoulos D. Biochemistry. 36:1997;66-75.
39. Allen T.M., Agrawal A.K., Ahmad I., Hansen C.B., Zalipsky S. J Liposome Res. 4:1994;1-25.
40. Hansen C.B., Kao G.Y., Moase E.H., Zalipsky S., Allen T.M. Biochim Biophys Acta. 1239:1995;133-144.
41. Park J.W., Hong K., Kirpotin D.B., Colbern G., Shalaby R., Baselga J.et al. Clin Cancer Res. 8:2002;1172-1181.
42. Martin F.J., Hubbell W.I., Papahadjopoulos D. Biochemistry. 20:1981;4229-4238.
43. Martin F.J., Papahadjopoulos D. J Biol Chem. 257:1982;286-288.
44. Zalipsky S. Bioconjug Chem. 4:1993;296-299.
45. Torchilin V.P., Levchenko T.S., Lukyanov A.N., Khaw B.A., Klibanov A.L., Rammohan R.et al. Biochim Biophys Acta. 1511:2001;397-411.
46. Bendas G., Krause A., Bakowsky U., Vogel J., Rothe U. Int J Pharm. 181:1999;79-93.
47. Ishida T., Iden D.L., Allen T.M. FEBS Lett. 460:1999;129-133.
48. Iden D.L., Allen T.M. Biochim Biophys Acta. 1513:2001;207-216.
49. Allen T.M., Sapra F., Moase E. Cell Mol Biol Letters. 7:2002;889-894.
50. Moreira J.N., Ishida T., Gaspar R., Allen T.M. Pharm Res. 19:2002;265-269.
51. Lopes de Menezes D.E., Pilarski L.M., Allen T.M. Cancer Res. 58:1998;3320-3330.
52. Dubowchik G.M., Walker M.A. Pharm Therap. 83:1999;67-123.
53. Kuby J. Immunology, 3rd ed. New York: W.H. Freeman and company; 1997. p. 573-95.
54. Flavell D.J., Noss A., Pulford K.A.F., Ling N., Flavell S.U. Cancer Res. 57:1997;4824-4829.
55. Regimbald L.H., Pibarski L.M., Longenecker B.M., Reddish M.A., Zimmermann G., Hugh J.C. Cancer Res. 56:1996;4244-4249.
56. van Hof A.C., Moithoff C.F.M., Davies Q., Perkins A.C., Verheijen R.H.M., Kenemans P.et al. Cancer Res. 56:1996;5179-5185.
57. Huang A., Kennel S.J., Huang L. J Biol Chem. 258:1983;14034-14040.
58. Allen T.M. Trends Pharmacol Sci. 15:1994;215-220.
59. Sugano M., Egilmez N.K., Yokota S.J., Chen F.A., Harding J., Huang S.K.et al. Cancer Res. 60:2000;6942-6949.
60. Drummond D.C., Hong K., Park J.W., Benz C.C., Kirpotin D.B. Vitam Horm. 60:2001;285-332.
61. Goren D., Horowitz A.T., Zalipsky S., Woodle M.C., Yarden Y., Gabizon A. Br J Cancer. 74:1996;1749-1756.
62. Vingerhoeds M.H., Steerenberg P.A., Hendriks J.J.G.W., Kekker L.C., van Hoesel Q.G.C.M., Crommelin D.J.A.et al. Br J Cancer. 74:1996;1023-1029.
63. Sapra P., Allen T.M. Cancer Res. 62:2002;7190-7194.
64. Lopes de Menezes D.E., Kirchmeier M.J., Gagne J.-F., Pilarski L.M., Allen T.M. J Liposome Res. 9:1999;199-228.
65. Ishida T., Kirchmeier M.J., Moase E.H., Zalipsky S., Allen T.M. Biochim Biophys Acta. 1515:2001;144-158.
66. Kirchmeier M.J., Ishida T., Chevrette J., Allen T.M. J. Liposome Res. 11:2001;15-29.
67. Straubinger R.M., Hong K., Friend D.S., Papahadjopoulos D. Cell. 32:1983;1069-1079.
68. Park J.W., Hong K., Carter F., Asgari H., Guo L.Y., Keller G.A.et al. Proc Natl Acad Sci USA. 92:1995;1327-1331.
69. Allen T.M. Nat Rev Cancer. 2:2002;750-763.
70. Nielsen U.B., Marks J.D. Pharm Sci Technol Today. 3:2000;282-291.
71. Poul M.A., Becerrib B., Nielsen U.B., Morisson F., Marks J.D. J Mol Biol. 301:2000;1149-1161.
72. Nielsen U.B., Kirpotin D.B., Pickering E.M., Hong K., Park J.W., Shalaby M.R.et al. Biochim Biophys Acta. 159l:2002;109-118.
73. Maruyama K., Takahashi N., Tagawa T., Nagaike K., Iwatsuru M. FEBS Lett. 413:1997;177-180.
74. Baxter L.T., Zhu H., Mackensen D.G., Jain R.K. Cancer Res. 54:1994;1517-1528.
75. Kohler G., Milstein C. Nature (London). 256:1975;495-497.
76. Schroff R.W., Foon K.A., Beatty S.M., Oldham R.K., Morgan A.C. Cancer Res. 48:1985;879-885.
77. Shawler D.L., Bartholomew R.M., Smith L.M., Dillman R.O. J Immunol. 135:1985;1530-1535.
78. Aragnol D., Leserman L. Proc Natl Acad Sci USA. 83:1986;2699-2703.
79. Maruyama K., Holmber E., Kennel S.J., Klibanov A., Torchilin V., Huang L. J Pharm Sci. 79:1990;978-984.
80. Phillips N.C., Emili A. Immunol Lett. 30:1991;291-296.
81. Harding J.A., Engbers C.M., Newman M.S., Goldstein N.I., Zalipsky S. Biochim Biophys Acta. 1327:1997;181-192.
82. Brekke O.H., Sandlie I. Nat Rev Cancer. 2:2003;52-62.
83. Winter G., Griffiths A.D., Hawkins R.E., Hoogenboom H.R. Annu. Rev. Immunol. 12:1994;433-455.
84. Fishwild D.M., O'Donnell S.L., Bengoechea T., Hudson D.V., Harding F., Bernhard S.L.et al. Nat Biotechnol. 14:1996;845-851.
85. Scheinberg D.A., Sgouros G., Junghans R.P. Chabner B.A., Longo D.L. Cancer chemotherapy and bioterapy. 2001;850-890 Lippincott Williams and Wilkins, Philadelphia.
86. Allen T.M., Sapra F., Moase E., Moreira J.N., Iden D.L. J Liposome Res. 121:2002;5-12.
87. Pastorino F., Brignole C., Marimpietri D., Sapra P., Moase E., Allen T.M.et al. Cancer Res. 63:2003;86-92.
88. Koning G.G.A., Morselt H.W.M., Gorter A., Allen T.M., Zalipsky S., Kamps J.A.A.M.et al. Phama Res. 18:2001;1291-1298.
89. Weinstein J.N., van Osdol W. Cancer Res. 52:1992;2747-2751.
90. Kirpotin D., Hong K., Mullah N., Papahadjopoubos D., Zalipsky S. FEBS Lett. 388:1996;115-118.
91. Vogel K., Wang S., Lee R.J., Chmielewski J., Low P.S. J Am Chem Soc. 118:1996;1581-1586.
92. Bailey A., Monck M.A., Cullis P.R. Biochim Biophys Acta. 1324:1997;232-244.
93. Connor J., Huang L. Cancer Res. 46:1986;3431-3435.
94. Kono K., Zenitani K., Takagishi T. Biochim Biophys Acta. 1193:1994;1-9.
95. Zignani M., Drummond D.C., Meyer O., Hong K., Leroux J.-C. Biochim Biophys Acta. 1463:2000;383-394.
96. Drummond D.C., Zignani M., Leroux J. Prog Lipid Res. 39:2000;409-460.
97. Stohrerm M., Boucher Y., Stangassinger M., Jain R.K. Cancer Res. 60:2000;4251-4255.
98. Huang S.K., Lee K.D., Hong K., Friend D.S., Papahadjopoulos D. Cancer Res. 52:1992;5135-5143.
99. Scherphof G.L., Kamps J.A.A.M., Koning G.A.J. Liposome Res. 7:1997;419-432.
100. Lopes de Menezes D.E., Pilarski L.M., Belch A.R., Allen T.M. Biochim Biophys Acta. 1466:2000;205-220.
101. Moase E., Qi W., Ishida T., Gabos Z., Longenecker B.M., Zimmermann G.L.et al. Biochim Biophys Acta. 1510:2001;43-55.
102. Moreira J.N., Gaspar R., Allen T.M. Biochim Biophys Acta. 1515:2001;167-176.
103. Koning G.A., Morselt J.M.W., Yelinova M.J., Donga J., Gorter A., Allen T.M.et al. Biochim Biophys Acta. 1420:1999;153-167.
104. Park J.W., Kirpotin D.B., Hong K., Shalaby R., Shao Y., Nielsen U.B.et al. J Control Release. 74:2001;95-113.
105. Asai T.K.S., Watanabe H., Ogino K., Taki T.S.S.A.M., Oku N. FEBS. lett:2002;520.
106. Park J.W., Hong K., Kirpotin D.B., Papahadjopoulos D., Benz C.C. Adv Pharmacol. 40:1997;399-435.
107. Lopes de Menezes D.E., Pilarski L.M., Allen T.M. Proc. Am. Assoc. Cancer Res. 36:1995;307.
108. Pagnan G., Montaldo P.G., Pastorino F., Chiesa L., Raffaghello L., Kirchmeier M.et al. J Cancer. 81:1999;268-274.
109. Allen T.M., Ahmad I., Lopes de Menezes D.E., Moase E.H. Biochem. Soc. Trans. 23:1995;1073-1079.
110. Pilarski L.M., Jensen G.S. Hematol Oncol Clin North Am. 6:1992;297-322.
111. Pilarski L.M., Masellis-Smith A., Szczepek A., Mant M.J., Belch A.R. Leuk Lymphoma. 18:1995;179-187.
112. Pilarski L.M., Belch A.R. Leuk Lymphoma. 17:1995;367-374.
113. Szczepek A.J., Bergsagel P.L., Axelsson L., Brown C.B., Belch A.R., Pilarski L.M. Blood. 89:1997;1824-1833.
114. Szczepek A.J., Seeberger K., Wizniak J., Mant M.J., Belch A.R., Pilarski L.M. Blood. 90:1998;2845-2855.
115. Tseng Y.L., Hong R.L., Tao M.H., Chang F.H. Int J Cancer. 80:1999;723-730.
116. Marty C., Odermatt B., Schott H., Neri D., Balimer-Hofer K., Klemenz R., Schwendener R.A. Brit J Cancer. 87:2002;106-112.
117. Nam S.M., Kim H.S., Ahn W.S., Park Y.S. Oncol Res. 11:1999;9-16.
118. Moreira J.N., Hansen C.B., Gaspar R., Allen T.M. Biochim Biophys Acta. 1514:2001;303-317.
119. Oku N., Asai T., Watanabe K., Kuromi K., Nagatsuka M., Kurohane K.et al. Oncogene. 21:2002;2662-2669.
120. Mastrobattista E., Koning G., Storm G. Adv Drug Del Rev. 40:1999;103-127.
121. Brekken R.A., Huang S., King S.W., Thorpe P.B. Cancer Res. 58:1998;1952-1959.
122. Brekken R.A., Thorpe F.E. Anticancer Res. 21:2001;4221-4229.
123. Tseng Y.-L., Liu J.-J., Hong R.-L. Mol Pharmacol. 62:2002;864-872.
124. Bongartz J.P., Anbertin A.M., Milhaud P.O., Lebleu B. Nucleic Acids Res. 22:1994;4681-4688.
125. Lu Y., Low P.S. Adv Drug Del Rev. 54:2002;675-693.
126. Lee R.J., Low P.S. Biochim Biophys Acta. 1233:1995;134-144.
127. Stephenson N.S., Lee R.J. Anticancer Res. 22:2002;2131-2135.
128. Guo W., Lee T., Sudimack J., Lee R.J. J Liposome Res. 10:2000;179-195.
129. Pan X.Q., Theng X., Shi G., Wang H., Ratnam M., Lee L.U. Blood. l00:2002;594-602.
130. Lu Y., Low P.S. Cancer Immunol Immunother. 51:2002;153-162.
131. Maruyama K., Ishida O., Takizawa T., Moribe K. Adv Drug Del Rev. 40:1999;89-102.
132. Ishida O., Maruyama K., Tanahashi H., Iwatsuru M., Sasaki K., Eriguchi M.et al. Pharm Res. 18:2001;1042-1048.
133. Eavarone D.A., Yu X., Bellamkonda R.V. J Biomed Mater Res. 51:1999;10. -l4.
134. Iinuma H., Maruyama K., Okinaga K., Sasaki K., Sekine T., Ishida O.et al. Int J Cancer. 99:2002;130-137.
135. Goren D., Horowitz A.T., Tzemack D., Tarshish M., Zalipsky S., Gabizon A. Clin Cancer Res. 6:2000;l949-1957.
136. Huwyler J., Cerletti A., Fricker G., Eberle A.N., Drewe J. J Drug Target. 10:2002;73-79.
137. Matsuo H., Wakasugi M., Takanaga H., Ohtani H., Naito M., Tsuruo T., Sawada Y. J Control Release. 77:2001;77-86.
138. Allen T.M., Moase E.H. Adv Drug Del Rev. 21:1996;117-133.
139. Maruyama K. Biol. Pharm Bull. 23:2000;791-799.
140. Koning G., Gorter A., Scherphof G., Kamps J. Br J Cancer. 80:1999;1718-1725.
141. Kessner S., Krause A., Rothe U., Bendas G. Biochim Biophys Acta. l514:2001;177-190.
142. Dagar S., Sekosan M., Lee B.S., Rubinstein I., Onyuksel H. J Control Release. 74:2001;129-134.
143. Jaafari M.R., Foidvari M. J Drug Target. 7:1999;101-112.
144. Medina O.P., Soderlund T., Laakkonen L.J., Tuominen E.K.J., Koivunen E., Kinnunen P.K.J. Cancer Res. 61:2001;3978-3985.
145. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M.M.et al. Bioconjug Chem. 10:1999;289-298.
146. Eliaz R.E., Szoka F.C.J. Cancer Res. 61:2001;2592-2601.